Lori J Goldstein, MD

Member
Medical Science Division

Director, Breast Evaluation Center
Leader, Breast Cancer Research Program

Lori.Goldstein@fccc.edu
Phone: 215-728-2689
Fax:

Recent Publications

2004

Anderson, P.R., Hanlon, A.L., Fowble, B.L., McNeeley, S.W., Freedman, G.M. Low complication rates are achievable after postmastectomy breast reconstruction and radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 59(4):1080-1087, 2004.

Barsevick, A.M., Dudley, W., Beck, S., Sweeney, C., Whitmer, K., Nail, L. A Randomized clinical trial of energy conservation for cancer-related fatigue. Cancer 100(6):1302-1310, 2004.

Beck, S.L., Schwartz, A.L., Towsley, G., Dudley, W., Barsevick, A.M. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J. Pain and Symptom Management 27(2):140-148, 2004.

Berger, A., Watson, J.C., Ross, E.A., Zalatoris, A., Hoffman, J.P. Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma. Am. Surg. 70(2):169-174, 2004.

Berger, A.C., Watson, J.C., Ross, E.A., Hoffman, J.P. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am. Surg. 70(3):235-240, 2004.

Golshan, M., Fung, B.B., Wiley, E., Wolfman, J., Rademaker, A., Morrow, M. Prediction of breast cancer size by ultrasound, mammography and core biopsy. The Breast 13:265-271, 2004.

Golub, R., Bennett, C.L., Stinson, T., Venta, L., Morrow, M. Cost minimization study of stereotactic core biopsy versus surgical excision biopsy. J. Clin. Oncol. 22:2430-2437, 2004.

Hynes, P.M., Weaver, F., Morrow, M., Folk, F., Winchester, D.P., Mallard, M. et al. Breast cancer surgery trends and outcomes: Results from a national Department of Veterans Affairs study. J. Am. Coll. Surg.198:707-716, 2004.

Khan, S.A., Wiley, E.L., Rodriquez, N., Baird, C., Ramakrishnam, R., Bryk, M., Bethke, K., Staradub, V.L., Wolfman, J., Rademaker, A., Ljung, B-M, Morrow, M. Ductal lavage findings in women with known breast cancer undergoing mastectomy. J. Natl. Cancer Inst. 96:1510-1517, 2004.

Konski, A. Will partial-breast irradiation (PBI) be a cost-effective alternative to whole breast irradiation (WBI) in the treatment of early stage breast cancer? Comm. Oncol. 1(2):93-97, 2004.

Lewis, N.L., Mullaney, M., Mangan, K.F., Klumpp, T., Rogatko, A., Broccoli, D. Lymphoid reconstitution: Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients. Bone Marrow Transplant 33:71-78, 2004.

Manne, S., Audrain, J., Schwartz, M., Main D., Finch, C., Lerman, C. Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Ann Behav Med. 2004 Dec;28(3):211-25.

Manne, S., Ostroff, J., Sherman, M., Heyman, R., Ross, S., Fox, K. Couples' support-related communication, psychological distress and marital satisfaction among women with early stage breast cancer. J. Consult. Clin. Psychol. 2004 Aug;72(4):660-70.

Meszoely, I.M., Lee, J.S., Watson, J.C., Michael Meyers, M., Wang, H., Hoffman, J.P. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas. Am. Surg. 70(3):208-214, 2004.

Meyers, M.O., Meszoely, I.M., Hoffman, J.P., Watson, J.C., Ross, E.A., Eisenberg, B.L. Is reporting of recurrence data important in pancreatic cancer? Ann. Surg. Oncol. 11(3):304-309, 2004.

Morrow, M., Harris, J.R. Ductal carcinoma in situ and microinvasive carcinoma. In Diseases of the Breast, Third Edition, edited by J.R. Harris, M.E. Lippman, M. Morrow, C.K. Osborne. Lippincott Williams & Wilkins, Philadelphia, pp. 521-540, 2004.

Morrow, M., Harris, J.R. Local management of invasive cancer: Breast. In Diseases of the Breast, Third Edition, edited by J.R. Harris, M.E. Lippman, M. Morrow, C.K. Osborne. Lippincott Williams & Wilkins, Philadelphia, pp. 719-744, 2004.

Morrow, M. Techniques in surgery: Lumpectomy for palpable and nonpalpable cancer. In Diseases of the Breast, Third Edition, edited by edited by J.R. Harris, M.E. Lippman, M. Morrow, C.K. Osborne. Lippincott Williams & Wilkins, Philadelphia, pp. 819-826, 2004.

Morrow, M., Staradub, V.L. Approach to a patient with a breast mass. In Women's Health. ACP Medicine Online, edited by D.C. Dale, D.D. Federman. WebMD Inc., New York (http://acpmedicine.com), April 2004.

Morrow, M. Magnetic resonance imaging in the preoperative evaluation of breast cancer: Primum non nocere. J Am Coll Surg. 198:240-241, 2004.

Morrow, M. The certainties and the uncertainties of ductal carcinoma in situ. J. Natl. Cancer Inst. 96:424-425, 2004. Morrow, M. Magnetic resonance imaging in breast cancer: One step forward, two steps back? JAMA 292:2779-2780, 2004.

Tchou, J., Hou, N., Rademaker, A., Jordan, V.C., Morrow, M. Acceptance of tamoxifen chemoprevention by physicians and women at risk. Cancer 100:1800-1806, 2004.

White, J., Moughan, J., Pierce, L.J., Morrow, M., Owen, J., Wilson, J.F. Status of postmastectomy radiotherapy in the United States: A patterns of care study. Int. J. Radiat. Oncol. Biol. Phys. 60:77-85, 2004.

2003

Biade, S., Murphy, M.E. Differential display techniques to identify tumor suppressor gene pathways. Methods Mol. Biol. 222:481-490, 2003.

Dumont, P.R.R.G., Leu, J., Della Pietra, A.C., George, D.L., Murphy, M. The codon 72 polymorphic variants of the p53 tumor suppressor protein demonstrate marked differences in apoptotic potential. Nat. Genet. 33:357-365, 2003.

Dumont, P., Della Pietra, A., Murphy, M.E. Methods to study p53-repressed promoters. Methods Mol. Biol. 234:111-120, 2003.

Ehya, H., Patchefsky, A. Bronchus-Associated Lymphoid Tissue (BALT) Lymphoma: Diagnosis by Fine Needle Aspiration Cytology and Flow Cytometry. Case Report and Review. Pathol. Case Rev. 8:267-274, 2003.

Endogenous Hormones and Breast Cancer Collaborative Group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J. Natl. Cancer Inst. 95:1218-1226, 2003.

Endogenous Hormones and Breast Cancer Collaborative Group. Validity of the calculation of free and non-SHBG bound estradiol and testosterone fractions in postmenopausal women and their use in breast cancer risk analyses. Cancer Epidemiol. Biomarkers Prev, 12:1457-1461, 2003.

Freedman, G.M., Anderson, P.R., Goldstein, L.J., Hanlon, A.L., Cianfrocca, M.E., Millenson, M.M., von Mehren, M., Torosian, M.H., Boraas, M.C., Nicolaou, N., Patchefsky, A.S., Evers, K. Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older. Cancer 98:918-925, 2003.

Henderson, I.C., Berry, D.A., Demetri, G.D., Cirrincione, C.T., Goldstein, L., Martino, S., Ingle, J.N., Cooper, M.R., Hayes, D.F., Borden, E.C., Fleming, G., Holland, J.F., Duggan, D.B., Carpenter, J.T., Frei, E., Schilsky, R.L., Wood, W.C., Muss, H.B., Norton, L. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J. Clin. Oncol. 21(6):976-83, 2003.

Lamar, C.A., Dorgan, J.F., Longcope, C., Stanczyk, F.Z., Falk, R.T., Stephenson, H.E. Serum sex hormones and breast cancer risk factors in postmenopausal women. Cancer Epidemiol. Biomark. Prev. 12:380-383, 2003.

Manne, S., Ostroff, J., Sherman, M., Glassman, M., Ross, S., Goldstein, L., Fox, K. Buffering effects for family and friend support on associations between partner unsupportive behaviors and coping among women with breast cancer. J. Soc. Pers. Relat. 20(6):771-792, 2003.

Mock, V., Atkinson, A., Barsevick, A., et al. (NCCN 2003) Cancer-related fatigue clinical practice guidelines in oncology. J. Natl. Comprehensive Cancer Network 1(3):308-331, 2003.

Murphy, M.E. The thousand doors that lead to death: p53-dependent repression and apoptosis. Cancer Biol. Ther. 2:381-382, 2003.

Patchefsky, A.S. Chapter 25, In Diagnostic Surgical Pathology, Fourth Edition, Nonneoplastic Pulmonary Disease, edited by S.S. Sternberg, Lippincott Williams & Wilkins, Philadelphia, 2003.

Patchefsky, A., Burk, M. Chapter 1, Pathology of Ovarian Tumors. In ACS Atlas of Oncology. edited by A. Patchefsky, M. Burk, B.C. Decker, Inc., Ontario, Canada, 2003.

Patchefsky, A., Goldberg, M. Unusual Bronchial Tumors. In Chest Surgery Clinics of North America, edited by A. Patchefsky, M. Goldberg, W.B. Saunders, Philadelphia, 2003.

Roth, M., Baer, D., Albert, P.S., Castonguay, T.W., Dorgan, J.F., Dawsey, S.M., Brown, E.D., Hartman, T.J., Campbell, W., Giffen, C., Judd, J.T., Taylor, P.R. The association between serum leptin and alcohol consumption in a controlled feeding and alcohol ingestion study. J. Natl. Cancer Inst. 95:1722-1725, 2003.

Sax, J.K., Stoddard, A., Murphy, M.E., Chodosh, L., El-Deiry, W.S. Microarray expression profiling of p53-dependent transcriptional changes in an immortalized mouse embryo fibroblast cell line. Cancer Biol. Ther. 2:416-430, 2003.

Sturgeon, S.R., Potischman, N., Malone, K.E., Dorgan, J.F., Daling, J., Schairer, C., Brinton, L.A. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study. Cancer Causes Control 15(1):45-53, 2004. Trauth, D., Goldstein, L.J. Adjuvant Therapy: Taxanes. J. Natl. Comprehensive Cancer Network 1(2):222-229, 2003.

Winer, E.P., Hudis, C., Burstein, J.B., Chlebowski, R.T., Ingle, J.N., Edge, S.B., Mamounas, E.P., Gelber, R., Grlow, J., Goldstein, L.J., Pritchard, K.I., Braun, S., Cobleigh, M.A., Langer, A.S., Perotti, J., Powles, T.J., Whelan, T.J., Browman, B.P. American Society of Clinical Oncology Technology Assessment Working Group update: use of aromatase inhibitors in the adjuvant setting. J. Clin. Oncol. 21(13):2597-2599, 2003.

2002

Freedman, G.M., Hanlon, A.L., Fowble, B.L., Anderson, P.R., Nicolaou, N., Nicoloau, N. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J. Clin. Oncol. 20:4015-4021, 2002.

Russin, M.P., Goldstein, L.J. Chemotherapy in breast cancer. Breast Cancer - A Guide to Detection and Multidisciplinary Therapy 9:145-159, 2002.

Winer, E.P., Hudis, C., Burstein, H.J., Chlebowski, R.T., Ingle, J.N., Edge, S.B., Mamounas, E.P., Gralow, J., Goldstein, L.J., Pritchard, K.I., Braun, S., Cobleigh, M.A., Langer, A.S., Perotti, J., Powles, T.J., Whelan, T.J., Browman, G.P. American Society of Clinical Oncology technical assessment on the use of Aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: Status Report 2002. J. Clin. Oncol. 20(15):3317-3327, 2002.